PLUS1
1,329.00
-9.00 (-0.67%)
-9.00 (-0.67%)
Upgrade to Real-Time
Market Open
Low
1,190.80
High
1,742.40
Best deals to access real time data! |
|
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
$29.56
|
|
London Stock Exchange Level 2
Monthly Subscription
for only
$77.61
|
|
Real-time London Stock Exchange & FTSE
Monthly Subscription
for only
$88.69
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Glaxosmithkline Plc | GSK | London | Ordinary Share | GB0009252882 | ORD 25P |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -9.00 | -0.67% | 1,329.00 | 08:28:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1,332.40 | 1,327.00 | 1,345.00 | 1,338.00 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1,329.00 | 1,329.20 | 0.20 | - | 2 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,476 | 1,964,119 | 1,334.46p | 26,210,451p | - | 1,190.80 - 1,742.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:29:06 | O | 1,100 | 1,329.19p | GBX |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
Glaxosmithkline Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 67.32Bp | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Glaxosmithkline News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/19/2021 | 09:08 | PR Newswire (US) | Advil to Reduce Plastic in Over 80 Million Bottles by 20%.. |
| 4/16/2021 | 11:00 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 4/15/2021 | 12:04 | Alliance News |  GlaxoSmithKline says EMA to review VIR-7831 Covid-19.. |
| 4/15/2021 | 12:01 | Dow Jones News | GlaxoSmithKline Up Over 5%, on Pace for Largest Percent.. |
| 4/15/2021 | 10:57 | Dow Jones News | GSK, Vir Say EMA Starts Review of VIR-7831 for Covid-19 |
| 4/15/2021 | 10:21 | UK Regulatory (RNS & others) | GlaxoSmithKline PLC Director/PDMR Shareholding |
| 4/15/2021 | 09:21 | Dow Jones News | Elliott Management Builds Significant Stake in GSK -FT |
Glaxosmithkline Discussion Forums - GSK
| Date | Time | Comments | Title |
|---|---|---|---|
| 12/15/2020 | 06:15 | - | Achiko AG: The One Ecosystem that Takes a |
| 11/15/2020 | 09:15 | - | [b]Breaking News: $GSK[/b] Investors Wish They Could Vote |
| 10/15/2020 | 10:09 | - | Decitabine has been shown to induce cancer-testis antigen |
| 10/14/2020 | 15:18 | - | SITC Decitabine gene modulation sensitizes human non–small cell lung |
| 9/12/2020 | 09:12 | - | Going forward, I would like them to transduce |
| 9/12/2020 | 09:04 | - | Lyell plan to use defined cell populations [1], |
| 9/08/2020 | 12:41 | - | Hopefully, trials testing these improvements will start early |
| 9/08/2020 | 11:29 | - | A new trial testing the NY-ESO-1 TCR-T cell |
| 8/09/2020 | 06:16 | - | Better Development Tools for a New Golden Era |
| 8/05/2020 | 18:57 | - | Calls might sky rocket tomorrow |
Historical GSK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1,292.20 | 1,388.40 | 1,269.20 | 1,333.37 | 11,489,531 | 36.80 | 2.85% |
| 1 Month | 1,300.20 | 1,388.40 | 1,269.20 | 1,308.12 | 10,490,778 | 28.80 | 2.22% |
| 3 Months | 1,405.00 | 1,423.20 | 1,190.80 | 1,278.97 | 10,752,315 | -76.00 | -5.41% |
| 6 Months | 1,403.80 | 1,482.20 | 1,190.80 | 1,331.18 | 10,292,485 | -74.80 | -5.33% |
| 1 Year | 1,660.60 | 1,742.40 | 1,190.80 | 1,441.80 | 9,029,676 | -331.60 | -19.97% |
| 3 Years | 1,419.00 | 1,857.00 | 1,190.80 | 1,537.27 | 9,185,167 | -90.00 | -6.34% |
| 5 Years | 1,501.50 | 1,857.00 | 1,190.80 | 1,527.98 | 9,213,553 | -172.50 | -11.49% |
